Skip to Main Content
1-877-YALEMDS
1-877-YALEMDS
Phase III

Jasmine: A Multicenter, Parallel-group, Double-blind, 2-Arm, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared with Placebo Added to Standard of Care in Adult Participants with Polymyositis

  • Study HIC#:2000035992
  • Last Updated:03/24/2026

    Contact Us

    For more information about this study, including how to volunteer, contact:

    Manisha Gupta

    Help Us Discover!

    You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.

    CREATE A VOLUNTEER PROFILE

    Principal Investigator

    For more information about this study, including how to volunteer, contact:

    Manisha Gupta